Page last updated: 2024-08-17

4-nitroquinoline-1-oxide and decitabine

4-nitroquinoline-1-oxide has been researched along with decitabine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albert, M; Gudas, LJ; Scognamiglio, T; Tang, XH1

Other Studies

1 other study(ies) available for 4-nitroquinoline-1-oxide and decitabine

ArticleYear
A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
    Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:12

    Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinogens; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Cyclooxygenase 2; Decitabine; DNA Modification Methylases; Female; Immunoenzyme Techniques; Mice; Mice, Inbred C57BL; Mouth Mucosa; Mouth Neoplasms; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myb; Receptors, Retinoic Acid; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin

2009